IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,935,809 | +97.9% | 1,144,334 | -2.2% | 0.01% | +66.7% |
| Q2 2023 | $22,204,827 | +36.5% | 1,170,523 | +11.6% | 0.00% | +50.0% |
| Q1 2023 | $16,265,621 | +91213.2% | 1,048,718 | +4.5% | 0.00% | 0.0% |
| Q4 2022 | $17,813 | -99.6% | 1,003,595 | +23.3% | 0.00% | +100.0% |
| Q3 2022 | $4,540,000 | +46.5% | 813,669 | +2.4% | 0.00% | – |
| Q2 2022 | $3,100,000 | -28.7% | 794,972 | +0.8% | 0.00% | -100.0% |
| Q1 2022 | $4,346,000 | -37.8% | 788,838 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $6,989,000 | -6.0% | 820,399 | -4.1% | 0.00% | 0.0% |
| Q3 2021 | $7,437,000 | -16.9% | 855,908 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $8,953,000 | -29.8% | 847,110 | +6.5% | 0.00% | -50.0% |
| Q1 2021 | $12,756,000 | -63.4% | 795,320 | +5.4% | 0.00% | -66.7% |
| Q4 2020 | $34,849,000 | +77.3% | 754,490 | +35.1% | 0.01% | +50.0% |
| Q3 2020 | $19,652,000 | +123.2% | 558,481 | +54.5% | 0.00% | +100.0% |
| Q2 2020 | $8,804,000 | +2854.4% | 361,569 | +1785.6% | 0.00% | – |
| Q1 2020 | $298,000 | – | 19,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |